The effectiveness of any peptide depends not just on the molecule itself but on how it's delivered to its target receptors. Different delivery methods have dramatically different bioavailability — the percentage of the administered dose that actually reaches systemic circulation.
Subcutaneous injection remains the gold standard for most therapeutic peptides because peptides are fragile molecules — stomach acid and digestive enzymes destroy most of them when taken orally. However, ongoing research has produced peptide formulations specifically designed for non-injection delivery.
Subcutaneous peptide injection achieves near 100% bioavailability. Oral peptides that survive digestion can achieve 20–80% depending on formulation. Sublingual delivery achieves 50–80% by bypassing the GI tract through buccal mucosa absorption.
Your physician will select the appropriate delivery format based on the peptide, your goals, and your lifestyle. Many patients use injection for their primary protocols and add non-injection formats for daytime or convenience use.